I52T (p.Ile52Thr) variant of NFKBIA (NF-kappa-B inhibitor alpha)

I52T (p.Ile52Thr) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

I52T (p.Ile52Thr) variant details